Q3 2019

Revenue of $7.5 Billion Increased 2.4% Reported; Increased 4.4% Organic

GAAP Diluted EPS of $0.94; Non-GAAP Diluted EPS of $1.29

Operating Margin of 20.4% Increased 90 bps; Non-GAAP Operating Margin of 29.2% Increased 140 bps

Cash Flow from Operations of $4.9 Billion in First Nine Months vs. $3.6 Billion in Prior Year; Free Cash Flow of $4.1 Billion in First Nine Months vs. $2.9 Billion in Prior Yea

Company Raises FY19 EPS and Free Cash Flow Guidance


"Our organization executed on multiple fronts to deliver a strong quarter for Medtronic," said Omar Ishrak, Medtronic chairman and chief executive officer. "Revenue outperformance in our Minimally Invasive Therapies and Restorative Therapies Groups, as well as broad strength across Emerging Markets, helped to offset certain market-specific headwinds we faced during the quarter, reflecting the full benefits of our diversification."

Press Release| Investors

| Medtronic

A Medtronic PLC (NYSE: MDT) divulgou seu resultado trimestral na terça-feira, 19 de fevereiro. A empresa reportou lucro de US $ 1,29 por ação no trimestre, superando a estimativa do mercado, que era de US $ 1,24, por US $ 0,05. A empresa reportou receita de US $ 7,55 bilhões no trimestre, ao passo que a estimativa de consenso era de US $ 7,53 bilhões. A Medtronic teve um retorno sobre o patrimônio líquido de 13,51% e uma margem líquida de 7,44%. A receita da empresa cresceu 2,4% na comparação ano a ano. Durante o mesmo período do ano anterior, a empresa reportou lucro de US $ 1,17 por ação.

NYSE:MDT - Stock Price, News, & Analysis for Medtronic